RxDoctor Payments Data

Barbara Santana Sanchez, APRN

Family · Kissimmee, FLNPI 1538783816

Payments from drug & device makers

$657in general payments, 2019–2025

Across 35 payments — averaging $18.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$129
  • Biohaven Pharmaceutical Holding Company Ltd.$127
  • Exact Sciences$68
  • AstraZeneca$52
  • Pfizer$45
  • AbbVie$43
  • plus $192 from 9 others

What the payments were for

  • Food & beverage$64598%
  • Education$122%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$657 in reported general payments places this provider in the 60th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$13,406
Medicare patients
72
Services billed
400

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide45$56,248
FarxigaDapagliflozin Propanediol25$25,386
LinzessLinaclotide14$21,449
OzempicSemaglutide11$20,677
EliquisApixaban23$18,243
Celecoxib58$3,755
Azelastine-FluticasoneAzelastine/Fluticasone16$1,514
Albuterol Sulfate HfaAlbuterol Sulfate52$1,239
Gabapentin79$1,237
Rosuvastatin Calcium101$1,166
Omeprazole50$857
Levothyroxine Sodium66$823
Alprazolam85$682
Ezetimibe25$670
Atorvastatin Calcium106$629

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$40$56,24845 claims
AstraZenecaFarxiga$52$25,38625 claims
AbbVieLinzess$43$21,44914 claims
Novo NordiskOzempic$16$20,67711 claims
PfizerEliquis$45$18,24323 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 14,618 family providers in Florida.

Other family in Kissimmee

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →